These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 1361760

  • 1. Failure of CAPD patients to respond to an oral iron absorption test.
    Domoto DT, Martin KJ.
    Adv Perit Dial; 1992; 8():102-4. PubMed ID: 1361760
    [Abstract] [Full Text] [Related]

  • 2. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL, Moles K, Pope K, Hargrove P.
    Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Infusion of total dose iron versus oral iron supplementation in ambulatory peritoneal dialysis patients: a prospective, cross-over trial.
    Ahsan N.
    Adv Perit Dial; 2000; 16():80-4. PubMed ID: 11045266
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB, Bárány P, Cazzola M, Eschbach JW, Grützmacher P, Kaltwasser JP, Macdougall IC, Pippard MJ, Shaldon S, van Wyck D.
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 16. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S, Tutal E, Arat Z, Akçay A, Celik H, Ozdemir FN, Haberal M.
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [Abstract] [Full Text] [Related]

  • 17. Long-term effect of oral calcitriol single weekly pulse in CAPD and in HD.
    Romanini D, Gazo A, Bellazzi R, de Vincenzi A, Nai M, Santagostino M.
    Adv Perit Dial; 1994 Oct; 10():267-9. PubMed ID: 7999842
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of zinc supplements on the nutritional status of patients undergoing continuous ambulatory peritoneal dialysis].
    Munguía C, Paniagua R, Avila-Díaz M, Nava-Hernández J, Rodríguez E, Ventura Mde J, Amato D.
    Rev Invest Clin; 2003 Oct; 55(5):519-27. PubMed ID: 14968473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.